Code is covered without prior authorization (high confidence)
Medicare Pricing
Work RVU
5.38
Facility
$548.44
Non-Facility
$548.44
Documentation Required
For BIPAP/related devices coverage for nocturnal hypoventilation/restrictive thoracic disorders: documentation of qualifying diagnosis codes (G47.34, G47.36, G70.*, J40-J44, M95.4, Q67.8) and clinical documentation that CPAP is intolerant or ineffective
General implication: sleep study results (in-lab polysomnography or appropriately conducted home sleep test meeting device channel requirements) and relevant clinical notes documenting symptoms, prior CPAP trial/intolerance, and comorbid conditions/tests (blood pressure, Epworth, MSLT) are required as part of selection criteria (these specific documentation elements are referenced in the policy text)
For CPAP and PAP device/accessory claims: documentation of device prescription, indication (diagnosis and AHI/comorbidity/symptom documentation as required), and any documentation of prior trials/education or reasons for intolerance where alternative devices are requested.
Key Coverage Criteria
Continuous Positive Airway Pressure (CPAP) devices and accessories — HCPCS E0601 and listed masks/interfaces/accessories (A7027–A7046, A7037–A7039, E0561–E0562, etc.) covered for obstructive sleep apnea (G47.33) when selection criteria are met (AHI thresholds specified).
CPAP coverage with AHI ≥15 for OSA (G47.33) — CPAP is covered when selection criteria (AHI ≥15) are met.
CPAP coverage with AHI 5–14 for OSA when specified comorbid conditions (see list above) or excessive sleepiness criteria are present — CPAP covered when selection criteria met.
AutoPAP/APAP and pressure-relief technologies (e.g., C-Flex) — covered under applicable HCPCS when selection criteria for CPAP/APAP are met.
Bi-level PAP and respiratory assist devices (E0470, E0472) — covered for OSA members intolerant of CPAP or when CPAP/AutoPAP is ineffective; covered for diagnoses with nocturnal hypoventilation (G47.34, G47.36) and for restrictive thoracic and chronic lower respiratory disease diagnoses (G70.*, J40–J44, M95.4, Q67.8) when selection criteria are met.
Testing for OSA is considered medically necessary for individuals who present with clinical features suggestive of moderate to severe OSA as evidenced by: 1) Excessive daytime sleepiness (EDS) and ONE of the following are present: a) BMI greater than 30; or b) Excessive sleepiness while driving; or c) Loud/intense snoring; 2) Epworth Sleepiness Scale (ESS) score of 10 or greater; or 3) Witnessed nocturnal apnea, choking and/or gasping.
1 Active Policy
AETNA-CPB-0004 — Obstructive Sleep Apnea in Adults
Ask Verity about documentation requirements, denial risks, or coverage in your state.
For therapies/devices listed as not covered: documentation supporting medical necessity will generally not result in coverage for those specific codes/devices for OSA indications per the CPB; the policy enumerates the list of non-covered items.
For Inspire UAS: documentation of CPAP failure or intolerance (CPAP failure defined as AHI >20 on CPAP; intolerance defined as use <4 hours/night on ≥5 nights/week or unwillingness to use).
For CPAP/APAP coverage: documentation of a positive facility-based NPSG or positive home sleep test (Type II, III, IV(A) or Watch-PAT) with AHI or RDI results meeting numeric thresholds and minimum event counts (AHI/RDI ≥15 with ≥30 events, or AHI/RDI 5–14 with ≥10 events plus qualifying comorbidity/symptom).